featured
Association of DPP-4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes
JAMA Dermatol 2019 Jan 09;[EPub Ahead of Print], SG Lee, HJ Lee, MS Yoon, DH KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.